Abstract:Introduction: Breast cancer (BC) remains a leading cause of cancer-associated mortality for women in the USA, which makes it critically important to identify and study molecular drivers of pathogenesis. We have previously identified the chromatin modifying DEK protein to have oncogenic properties. DEK is a histone H3 chaperone that is over-expressed in over 60% of breast cancers, particularly triple negative breast cancers, and is associated with poor survival. To date, all studies regarding the role of DEK in BC have manipulated DEK expression in cultured immortalized MCF10A human mammary epithelial cells and BC cell lines. However, the oncogenic functions of DEK in vivo and in normal mammary epithelium have remained unexplored. Methods: We utilized a tetracycline-off regulated, DEK overexpressing (DEK-OE) transgenic mouse model that targets mammary epithelium through the mouse mammary tumor virus (MMTV) promoter. We subsequently performed bulk RNA-Seq transcriptomic analyses, western blotting, and both histological and morphological assessments of control vs. DEK-OE mammary gland tissue to identify the oncogenic effects of DEK over-expression in vivo. Results: Bulk RNA sequencing and gene ontology analyses identified cell cycle regulation as a significantly upregulated biological process in DEK-OE versus control glands. Subsequent studies confirmed upregulation of proteins that promote the G1-S cell cycle transition including cyclins A and D and CDKs 2, 4, and 6 as well as increased numbers of Ki67+ cells. We also observed down-regulation of genes that inhibit entry the G1-S transition, such as p21 and p27. This pro-proliferative molecular status correlated with the development of mammary gland hyperplasia. Importantly, in silico analyses demonstrated gene correlations between DEK and cell cycle regulators that were also evident in human breast cancers. One potential mechanism for this transcriptional deregulation is that we identified increased histone H3K27me3 epigenetic modifications in DEK-OE cells, in both mouse and human models, which may occur through EZH2 activity. Conclusions: Combined, our work indicates that DEK is not a tumor initiator, but its oncogenic activities are likely due to its ability to promote proliferation of mammary epithelial cells. Furthermore, we report a novel function for DEK in the epigenetic regulation of histone H3 K27 trimethylation, which is mediated by the well-known EZH2 oncogene in triple negative breast cancers. Citation Format: Megan Johnstone, Ashley Leck, Taylor Lange, Lisa Privette Vinnedge. DEK overexpression in the murine mammary gland promotes epithelial hyperplasia [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1) nr A084.

DEK Modulates Both Expression and Alternative Splicing of Cancer-Related Genes

Expression of DEK in Pancreatic Cancer and Its Correlation with Clinicopathological Features and Prognosis

Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer.

Oncogene DEK is Highly Expressed in Lung Cancerous Tissues and Positively Regulates Cell Proliferation As Well As Invasion.

Critical Role of DEK and Its Regulation in Tumorigenesis and Metastasis of Hepatocellular Carcinoma

DEAD-Box Helicase 27 Triggers Epithelial to Mesenchymal Transition by Regulating Alternative Splicing of Lipoma-Preferred Partner in Gastric Cancer Metastasis.

The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis

Overexpression of DEK is an Indicator of Poor Prognosis in Patients with Gastric Adenocarcinoma.

Prognostic Role of DEK in Human Solid Tumors: a Meta-Analysis

Regulation of DEK Expression by AP-2α and Methylation Level of DEK Promoter in Hepatocellular Carcinoma.

KPNA2 promotes the progression of gastric cancer by regulating the alternative splicing of related genes

DEK Proto-Oncogene is Highly Expressed in Astrocytic Tumors and Regulates Glioblastoma Cell Proliferation and Apoptosis

Significance of DEK Overexpression for the Prognostic Evaluation of Non-Small Cell Lung Carcinoma.

DEK-rRNA interactions regulate ribosome biogenesis and stress response

High Expression of DEK Predicts Poor Prognosis of Gastric Adenocarcinoma.

DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer

DEK mediates AKT/mTOR signaling pathway promotes the proliferation, migration and EMT process of cholangiocarcinoma

Dek over Expression As an Independent Biomarker for Poor Prognosis in Colorectal Cancer

Abstract A084: DEK overexpression in the murine mammary gland promotes epithelial hyperplasia

Hnrnpk Promotes Gastric Tumorigenesis Through Regulating CD44E Alternative Splicing.

DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35